Back to Agenda
Session 7: Blockchain
Session Chair(s)
Adama Ibrahim, MBA
Vice President, Digital Strategy and Change Management, Novo Nordisk, United Kingdom
Aji Barot
Head of Business Development, OPEN Health Group, United Kingdom
Blockchain technology increases security and speeds up the exchange of information in a way that is cost-effective and more transparent. This technology has been increasingly used and considered in the healthcare sector as it can be applied to several aspects of the drug discovery and development lifecycle, namely data management, clinical trials, supply chain compliance, among many others. At this session, you will hear key stakeholders and users of Blockchain in Drug Development discussing challenges, risks and benefits.
Speaker(s)
The Patient Advocate Perspective
Pathfinder for Patients and Caregivers, Teacher, CEO/Founder, CysticFibrosis.com, United States
Diversity and Inclusion, Entrepreneur and Ex-Regulator Perspective
Founder and CEO, IndyGeneUS AI, United States
Blockchain Industry, Consortia and Consensys roadmap
Chief Scientific Officer and FNO Coordination Lead, Equideum Health, United States
Blockchain Industry – Working with Hospitals during a Pandemic
Founder and Chief Executive Officer, ACOER and Ex-CDC, United States
The Clinician Perspective
Founder and Chief Executive Officer, SAAVHA Inc., United States
Have an account?